Close Menu

NEW YORK (GenomeWeb) – Natera has filed with the US Securities and Exchange Commission for a proposed $100 million common stock offering.

The San Carlos, California-based molecular diagnostics firm filed the automatic shelf registration statement at the close of the market Tuesday. Based on its closing price of $20.28 on Monday, Natera said that it would offer around 4.9 million shares.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A New Zealand minister says the country's genetic modification laws need to be re-examined to help combat climate change, the New Zealand Herald reports.

A new analysis finds some cancers receive more nonprofit dollars than others.

An Australian mother's conviction in the deaths of her children may be re-examined after finding that two of the children carried a cardiac arrhythmia-linked gene variant.

In Science this week: comparative analysis of sex differences in mammal gene expression, and more.